FDA inspection
Saint-Gobain Life Sciences (Hangzhou) Co., Ltd: FDA inspection ending May 11, 2017
FDA inspection 1012560 · Voluntary Action Indicated (VAI) · Hangzhou
Key facts
| Inspection ID | 1012560 |
|---|---|
| Firm | Saint-Gobain Life Sciences (Hangzhou) Co., Ltd |
| FEI number | 3008157119 |
| Address | Xiaoshan Qiaonan, 108 10th Hi-Tech Road; Xiaoshan |
| City | Hangzhou |
| Country | China |
| Fiscal year | 2017 |
| Inspection end date | May 11, 2017 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Postmarket Assurance: Devices |
| Product type | Devices |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data